dr. richards on secondary endpoints of the polo trial in pancreatic cancer
Published 4 years ago • 112 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:58
dr. richards on the phase iii polo trial in brca-mutated pancreatic cancer
-
3:56
polo trial in pancreatic cancer
-
0:47
dr. richards on parp inhibition in pancreatic cancer
-
0:57
dr. richards on using parp inhibitors in mutated metastatic pancreatic cancer
-
1:00
dr. macarulla discusses rapid progressors in the polo trial in pancreatic cancer
-
2:19
dr. hall discusses rationale for the polo trial in metastatic pancreatic cancer
-
1:42
dr. bekaii-saab on the apact trial in pancreatic cancer
-
3:45
parp inhibitors gbrca1/2-mutated pancreatic cancer
-
1:07
quality of life data for parp inhibitor shows promise for pancreatic cancer treatment
-
8:22
sequencing strategies in metastatic pancreatic cancer
-
4:12
emerging therapy for pancreas cancer
-
1:33
dr. sahai on sequencing strategies in metastatic pancreatic cancer
-
6:10
practical advice: pancreas cancer adjuvant therapy
-
0:52
dr. cohn on frontline therapies in metastatic pancreatic cancer
-
1:10
dr. hidalgo medina on treatment considerations in pancreatic cancer
-
5:32
metastatic pancreas cancer; salvage therapy
-
9:03
immunotherapy for msi-high pancreatic tumors
-
2:22
surgeon spotlight: dr. charles m. vollmer
-
7:05
the analysis of breakthrough research on pbc with kris kowdley